EUVIMEDEUVIMED entdecken
Kohortenstudie

Vildagliptin‐Induced Bullous Pemphigoid: A Retrospective Cohort Study

Karen Koch iD, Breana Lim

Australasian Journal of Dermatology · 2026

DOI: 10.1111/ajd.70039 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Australasian Journal of Dermatology, 2026. Verfasst von Karen Koch und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Waikato Hospital, Hamilton, Waikato, New Zealand. Hauptthemen laut MEDLINE: Vildagliptin, Pemphigoid, Bullous, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bullous pemphigoid (BP) is a common autoimmune blistering disease associated with medications, particularly dipeptidyl peptidase‐4 inhibitors such as vildagliptin, funded in New Zealand since 2018. We conducted a retrospective single‐centre study of histologically confirmed BP cases between 2018 and 2023. Of 49 patients identified, 15 (30.6%) had vildagliptin‐induced BP. Māori patients were over‐represented in this subgroup. The mean time to BP onset after vildagliptin initiation was 388 days. Non‐vildagliptin BP was more likely to require systemic immunosuppression. Vildagliptin‐induced BP represents a common and under‐recognised clinical entity in New Zealand.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VildagliptinPemphigoid, BullousDipeptidyl-Peptidase IV InhibitorsHumansRetrospective StudiesFemaleMaleAgedAged, 80 and overNew ZealandMiddle Aged

Stichwörter der Autor:innen

bullous pemphigoiddipeptidyl peptidase‐4 (DPP‐4) inhibitorsgliptin‐induced bullous pemphigoidvildagliptin‐induced bullous pemphigoid

Substanzen

VildagliptinDipeptidyl-Peptidase IV Inhibitors

Autor:innen und Institutionen

  • Department of Dermatology, Waikato Hospital, Hamilton, Waikato, New Zealand.
  • Medical School, University of Auckland, Auckland, Auckland, New Zealand.

ORCID-Profile: Karen Koch

Zitieren

APA

Koch, K., & Lim, B. (2026). Vildagliptin‐Induced Bullous Pemphigoid: A Retrospective Cohort Study. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.70039

Vancouver

Koch K, Lim B. Vildagliptin‐Induced Bullous Pemphigoid: A Retrospective Cohort Study. Australasian Journal of Dermatology. 2026. doi:10.1111/ajd.70039

BibTeX
@article{Koch2026,
  author = {Koch, Karen and Lim, Breana},
  title = {Vildagliptin‐Induced Bullous Pemphigoid: A Retrospective Cohort Study},
  journal = {Australasian Journal of Dermatology},
  year = {2026},
  doi = {10.1111/ajd.70039}
}
Kostenlos starten →